NYSE:BDX
222.78
1.62
(0.73%)
Becton, Dickinson and Company is an American medical technology company that manufactures and sells medical devices, instrument systems, and reagents.
More at Wikipedia
Becton Dickinson
BDX-N
Analysis and Opinions about BDX-N
Signal
Opinion
Expert
BUY
BUY
August 25, 2020
Allan Tong’s Discover Picks The pandemic helped BDX, since most of its products are disposable. Then again, during the spring lockdown, surgeries were cancelled across the board, so use of BDX's products nearly halted. Its chart this year has been rocky, though earlier this month, the stock returned to previous highs above $280 while it has met or narrowly beat its EPS in the past four quarters. BDX continues to be profitable at a margin of 7.13% and a 15.41% five-year average revenue growth. Forward PE stands at 20.44x and it pays a dividend of 1.2%. Read BDX, BSX, ISRG and Stryker Stock: Top 4 Medical Supply Stocks for our full analysis.
Show full opinionHide full opinion
Allan Tong’s Discover Picks The pandemic helped BDX, since most of its products are disposable. Then again, during the spring lockdown, surgeries were cancelled across the board, so use of BDX's products nearly halted. Its chart this year has been rocky, though earlier this month, the stock returned to previous highs above $280 while it has met or narrowly beat its EPS in the past four quarters. BDX continues to be profitable at a margin of 7.13% and a 15.41% five-year average revenue growth. Forward PE stands at 20.44x and it pays a dividend of 1.2%. Read BDX, BSX, ISRG and Stryker Stock: Top 4 Medical Supply Stocks for our full analysis.
BUY
BUY
August 24, 2020
One of the better US healthcare companies, making needles and test tubes. BDX has done very well in recent years though flat during COVID, so he expects a catch-up. No reason to be afraid of this. It's a solid stock that will grow 3-5% annually.
Show full opinionHide full opinionOne of the better US healthcare companies, making needles and test tubes. BDX has done very well in recent years though flat during COVID, so he expects a catch-up. No reason to be afraid of this. It's a solid stock that will grow 3-5% annually.
PAST TOP PICK
PAST TOP PICK
July 31, 2020
(A Top Pick Jun 24/19, Up 12%) The only company that can manufacture disposable, consumable medical products, especially syringes. They benefit from the pandemic and will benefit from the aging population.
Show full opinionHide full opinion(A Top Pick Jun 24/19, Up 12%) The only company that can manufacture disposable, consumable medical products, especially syringes. They benefit from the pandemic and will benefit from the aging population.
PAST TOP PICK
PAST TOP PICK
June 15, 2020
(A Top Pick Jun 24/19, Down 6%) Hospitals were kind of closed across North America. These guys were a supplier for hospitals. If there are no surgeries then there is less demand for their one time use products. A billion plus doses of a vaccine will require their syringes.
Show full opinionHide full opinion(A Top Pick Jun 24/19, Down 6%) Hospitals were kind of closed across North America. These guys were a supplier for hospitals. If there are no surgeries then there is less demand for their one time use products. A billion plus doses of a vaccine will require their syringes.
TOP PICK
TOP PICK
April 21, 2020
Most of their medical devices are disposable, and now they have a new COVID test. So, 90% of revenues are recurring and will only increase by 14% in the coming 12 months and double-digits in years to follow. They are incredibly well-positioned and enjoy consistent demand. (Analysts’ price target is $268.53)
Show full opinionHide full opinionMost of their medical devices are disposable, and now they have a new COVID test. So, 90% of revenues are recurring and will only increase by 14% in the coming 12 months and double-digits in years to follow. They are incredibly well-positioned and enjoy consistent demand. (Analysts’ price target is $268.53)
COMMENT
COMMENT
February 14, 2020
Investing in healthcare is hard. He holds BDX which he sees it as the shopping mall of healthcare products. He used to own ZBH but they suffered from recalls. He would probably stick to one of the three since he believes they are the best run companies in healthcare.
SELL
SELL
February 12, 2020
A big miss in earnings and sold off. Move on. Maybe it finds its footing in a few days.
Show full opinionHide full opinionA big miss in earnings and sold off. Move on. Maybe it finds its footing in a few days.
HOLD
HOLD
February 7, 2020
The stock took a hit but he would hold. Their pump software is not working and they had to withdraw it from the market. Yesterday, they reduced their forward earnings $12-$12.10. He wouldn't buy it today, but if it falls to 15x earnings, he would pull the trigger. They started with needles and they have existed for over 100 years. They continue to pay down their debt and their dividends are rising at around 7%. You can invest in it and let the company do what it does.
Show full opinionHide full opinionThe stock took a hit but he would hold. Their pump software is not working and they had to withdraw it from the market. Yesterday, they reduced their forward earnings $12-$12.10. He wouldn't buy it today, but if it falls to 15x earnings, he would pull the trigger. They started with needles and they have existed for over 100 years. They continue to pay down their debt and their dividends are rising at around 7%. You can invest in it and let the company do what it does.
BUY
BUY
February 4, 2020
Good time to get into healthcare and which stock? The Canadian Tire of healthcare supplies. Medtronic is also good.
Good time to get into healthcare and which stock? The Canadian Tire of healthcare supplies. Medtronic is also good.
BUY
BUY
January 2, 2020
A very solid business, making most of the syringes etc. used in hospitals world-wide. This business is growing. They sell at 25+ times earnings because of the quality of the business. (Analysts’ price target is $282.00)
Show full opinionHide full opinionA very solid business, making most of the syringes etc. used in hospitals world-wide. This business is growing. They sell at 25+ times earnings because of the quality of the business. (Analysts’ price target is $282.00)
PAST TOP PICK
PAST TOP PICK
November 29, 2019
(A Top Pick Nov 02/18, Up 11%) Medical supplies giant. They've been around for 100 year. Syringes are their big product. They made a large acquisition but are paying down debt. They continue their investment grade credit. The medical supply business has done better than pharmaceuticals.
Show full opinionHide full opinion(A Top Pick Nov 02/18, Up 11%) Medical supplies giant. They've been around for 100 year. Syringes are their big product. They made a large acquisition but are paying down debt. They continue their investment grade credit. The medical supply business has done better than pharmaceuticals.
BUY WEAKNESS
BUY WEAKNESS
November 28, 2019
Favorable time to own health stocks in front of the US elections. A very solid investment you can certainly sleep at night with it. Would be a bit cautious on the purchase price and buy it on a downturn.
Show full opinionHide full opinionFavorable time to own health stocks in front of the US elections. A very solid investment you can certainly sleep at night with it. Would be a bit cautious on the purchase price and buy it on a downturn.
TOP PICK
TOP PICK
June 24, 2019
Just because the population is aging, doesn't mean you'll benefit from it. BDX is in medical supplies, not drugs, supplying hospitals. They've pulled back a little, because a product is under FDA review. They have a good record of raising their dividend, and they have a long runway of opportunities ahead. (Analysts’ price target is $259.67)
Show full opinionHide full opinionJust because the population is aging, doesn't mean you'll benefit from it. BDX is in medical supplies, not drugs, supplying hospitals. They've pulled back a little, because a product is under FDA review. They have a good record of raising their dividend, and they have a long runway of opportunities ahead. (Analysts’ price target is $259.67)
BUY
BUY
May 23, 2019
One of the solid players in the sector. The Health Care sector has been disrupted before elections as politicians take it out on the companies in the sector. Great time to buy it and hold it riding the volatility until the election.
Show full opinionHide full opinionOne of the solid players in the sector. The Health Care sector has been disrupted before elections as politicians take it out on the companies in the sector. Great time to buy it and hold it riding the volatility until the election.
BUY
BUY
May 17, 2019
A century-old company. Stumbled last quarter after the FDA pulled a product of theirs. They are great operators. They are paying down debt after an acquisition, but that will be finished soon. They have a wide moat. Good valuation, a slow grower and big in countries like China. Definitely look at it after a pullback.
Show full opinionHide full opinionA century-old company. Stumbled last quarter after the FDA pulled a product of theirs. They are great operators. They are paying down debt after an acquisition, but that will be finished soon. They have a wide moat. Good valuation, a slow grower and big in countries like China. Definitely look at it after a pullback.
Becton Dickinson(BDX-N) Rating
Ranking : 4 out of 5
Bullish - Buy Signals / Votes : 8
Neutral - Hold Signals / Votes : 1
Bearish - Sell Signals / Votes : 1
Total Signals / Votes : 10
Becton Dickinson(BDX-N) Frequently Asked Questions
What is Becton Dickinson stock symbol?
Becton Dickinson is a American stock, trading under the symbol BDX-N on the New York Stock Exchange (BDX). It is usually referred to as NYSE:BDX or BDX-N
Is Becton Dickinson a buy or a sell?
In the last year, 10 stock analysts published opinions about BDX-N. 8 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is BUY. Read the latest stock experts' ratings for Becton Dickinson.
Is Becton Dickinson a good investment or a top pick?
Becton Dickinson was recommended as a Top Pick by Stockchase Discover on 2020-08-25. Read the latest stock experts ratings for Becton Dickinson.
Why is Becton Dickinson stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Becton Dickinson worth watching?
10 stock analysts on Stockchase covered Becton Dickinson In the last year. It is a trending stock that is worth watching.
What is Becton Dickinson stock price?
On 2020-09-25, Becton Dickinson (BDX-N) stock closed at a price of $222.78.
